E-LIB Suche - Ergebnisse für: Grilley-Olson, J.E.

1

A phase Ib/II dose expansion study of subcutaneous sasanlim..:

Cho, B.C. ; Penkov, K. ; Bondarenko, I....
ESMO Open. 8 (2023) 4 - p. 101589 , 2023

Link: https://doi.org/10.1016/..

2

Phase I dose-escalation study of copanlisib in combination ..:

Kim, R D ; Alberts, S R ; Peña, C...
British Journal of Cancer. 118 (2018) 4 - p. 462-470 , 2018

Link: https://doi.org/10.1038/..

3

A phase Ib dose-escalation study of the MEK inhibitor trame..:

Grilley-Olson, J. E. ; Bedard, P. L. ; Fasolo, A....
Investigational New Drugs. 34 (2016) 6 - p. 740-749 , 2016

Link: https://doi.org/10.1007/..

4

Preliminary Results of a Phase 1b Study of Bavituximab (B) ..:

Grilley-Olson, J.E. ; Villaruz, L.C. ; Stinchcombe, T.E....
International Journal of Radiation Oncology*Biology*Physics. 90 (2014) 5 - p. S54 , 2014

Link: https://doi.org/10.1016/..

5

Phase 1 dose-escalation study of SEA-CD40: a non-fucosylate..:

Coveler, Andrew L ; Smith, David C ; Phillips, Tycel...
Journal for ImmunoTherapy of Cancer. 11 (2023) 6 - p. e005584 , 2023

Link: https://doi.org/10.1136/..

6

A League of Its Own? Established and Emerging Therapies in ..:

Graves, Laurie ; Jeck, William R. ; Grilley-Olson, Juneko E.
Current Treatment Options in Oncology. , 2023

Link: https://doi.org/10.1007/..

7

Larotrectinib Treatment for Patients With TRK Fusion-Positi..:

Le, Xiuning ; Baik, Christina ; Bauman, Jessica...
The Oncologist. 29 (2022) 6 - p. e779-e788 , 2022

Link: https://doi.org/10.1093/..

8

RARE-07. EFFICACY AND SAFETY OF LAROTRECTINIB IN PEDIATRIC ..:

Perreault, Sébastien ; Doz, François ; Geoerger, Birgit...
Neuro-Oncology. 23 (2021) Supplement_1 - p. i42-i42 , 2021

Link: https://doi.org/10.1093/..

9

Efficacy and safety of larotrectinib in TRK fusion-positive..:

Doz, François ; van Tilburg, Cornelis M ; Geoerger, Birgit...
Neuro-Oncology. 24 (2021) 6 - p. 997-1007 , 2021

Link: https://doi.org/10.1093/..

10

Association of Tumor Mutational Burden and Immune Gene Expr..:

Hu-Lieskovan, Siwen ; Braiteh, Fadi ; Grilley-Olson, Juneko E....
Targeted Oncology. 16 (2021) 6 - p. 773-787 , 2021

Link: https://doi.org/10.1007/..

11

CTNI-67. EFFICACY AND SAFETY OF LAROTRECTINIB IN PATIENTS W..:

Perreault, Sébastien ; Doz, François ; Drilon, Alexander...
Neuro-Oncology. 22 (2020) Supplement_2 - p. ii58-ii58 , 2020

Link: https://doi.org/10.1093/..

12

Novel induction therapy transoral surgery treatment paradig..:

Hackman, Trevor G. ; Patel, Samip N. ; Deal, Allison M....
Oral Oncology. 110 (2020) - p. 104957 , 2020

Link: https://doi.org/10.1016/..

13

EPCT-08. ACTIVITY OF LAROTRECTINIB IN PEDIATRIC TROPOMYOSIN..:

Goto, Hiroaki ; Geoerger, Birgit ; DuBois, Steven G...
Neuro-Oncology. 22 (2020) Supplement_3 - p. iii305-iii305 , 2020

Link: https://doi.org/10.1093/..

14

RARE-45. ACTIVITY OF LAROTRECTINIB IN TRK FUSION CANCER PAT..:

Doz, Francois ; Geoerger, Birgit ; DuBois, Steven G...
Neuro-Oncology. 21 (2019) Supplement_6 - p. vi231-vi231 , 2019

Link: https://doi.org/10.1093/..

15

Improved Tumor Purity Metrics in Next-generation Sequencing..:

Patel, Nirali M. ; Jo, Heejoon ; Eberhard, David A....
Applied Immunohistochemistry & Molecular Morphology. 27 (2019) 10 - p. 764-772 , 2019

Link: https://doi.org/10.1097/..